Aesthetic Medicine Market Research Report
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Aesthetic Medicine Market
5.1. COVID-19 Landscape: Aesthetic Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Aesthetic Medicine Market, By Procedure
8.1.Aesthetic Medicine Market, by Procedure Type, 2024-2033
8.1.1. Invasive Procedures
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Non-invasive Procedures
8.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Aesthetic Medicine Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Procedure (2021-2033)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Procedure (2021-2033)
Chapter 10. Company Profiles
10.1. AbbVie
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Cynosure
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Evolus Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Revance Galderma
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Lumenis
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Solta Medical
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Syneron Candela
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Alma Laser
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3.Financial Performance
10.8.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers